Article

CRISPR-Cas9 generated Pompe knock-in murine model exhibits early-onset hypertrophic cardiomyopathy and skeletal muscle weakness

2019-09-24

Abstract excerpt

Infantile-onset Pompe Disease (IOPD), caused by mutations in lysosomal acid alpha-glucosidase ( Gaa ), manifests rapidly progressive fatal cardiac and skeletal myopathy incompletely attenuated by synthetic GAA intravenous infusions. The currently available murine model does not fully simulate human IOPD, displaying skeletal myopathy with late-onset hypertrophic cardiomyopathy. Bearing a Cre- LoxP induced exonic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3aa7ba49-01c0-57a7-8711-916b5e76ea2f
DOI: 10.1101/780320

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

CRISPR-Cas9 generated Pompe knock-in murine model exhibits early-onset hypertrophic cardiomyopathy and skeletal muscle weaknessDOI 10.1101/780320Read

CRISPR-Cas9 generated Pompe knock-in murine model exhibits early-onset hypertrophic cardiomyopathy and skeletal muscle weaknessSemantic proximity Read

CRISPR-mediated generation and characterization of a Gaa homozygous c.1935C>A (p.D645E) Pompe disease knock-in mouse model recapitulating human infantile onset-Pompe diseaseSemantic proximity Read

CRISPR-Mediated Generation and Characterization of a Gaa Homozygous c.1935C>A (p.D645E) Pompe Disease Knock-in Mouse Model Recapitulates Human Infantile Onset-Pompe DiseaseSemantic proximity Read

CRISPR-Mediated Generation and Characterization of a <i>Gaa</i> Homozygous c.1935C>A (p.D645E) Pompe Disease Knock-in Mouse Model Recapitulates Human Infantile Onset-Pompe DiseaseSemantic proximity Read

Generation and characterization of a novel Gaa compound heterozygous mouse model recapitulating human Pompe disease.Semantic proximity Read

A Skeletal Muscle Model of Infantile-onset Pompe Disease with Patient-specific iPS Cells.Semantic proximity Read

Screening chimeric GAA variants in preclinical study results in hematopoietic stem cell gene therapy candidate vectors for Pompe diseaseSemantic proximity Read

Pompe disease gene therapy: neural manifestations require consideration of CNS directed therapySemantic proximity Read

A Genome Engineered Human Embryonic Stem Cell line to Investigate Pompe DiseaseSemantic proximity Read

Gene Therapy Developments for Pompe DiseaseSemantic proximity Read

Screening of Chimeric GAA Variants in a Preclinical Study of Pompe Disease Results in Candidate Vector for Hematopoietic Stem Cell Gene TherapySemantic proximity Read

Long-Term Functional Correction of Pompe Disease and Increased α-Glucosidase Expression after Gene Therapy with Novel Combinations of Muscle-Targeted Transcriptional Cis -Regulatory ElementsSemantic proximity Read